UNH vs GILD
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Gilead Sciences, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | GILD |
|---|---|---|
| Price | $427.89 | $127.88 |
| Market cap | $388.59B | $158.77B |
| P/E ratio | 32.3 | 17.4 |
| ROE | 12.18% | 43.36% |
| Profit margin | 2.68% | 30.99% |
| Revenue growth | 2.00% | 4.40% |
| Dividend yield | 2.17% | 2.56% |
| Beta | 0.65 | 0.33 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs GILD in plain English
- UNH is the bigger company — about 2.4× the market cap of GILD.
- GILD is cheaper on earnings (P/E 17.4 vs 32.3).
- GILD earns a higher return on equity (43% vs 12%).
- GILD is growing revenue faster (4% vs 2%).
- GILD has the higher dividend yield (2.56% vs 2.17%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
GILD return calculator
See what $1,000 in Gilead Sciences, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.